Remimazolam

Remimazolam
Product Description

-Active Ingredients: Remimzaolam Bsylate -Excipients: Dextran 40, Lactose monohydrate, sodium hydroxide, hydrochloric acid -Dosage: 20mg, 50mg -Indication: 1. Byfavo Inj. 20mg The induction and maintenance of general anesthesia The induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less 2. Byfavo Inj. 50mg The induction and maintenance of general anesthesia in adults -GMP: EU, JP, KR -Stability: Zone IV b

Read more Show less

Hana Pharm. Co., Ltd.

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2025
  • Employees:
    500 - 999
Company types
Pharmaceutical company
View company profile

Hana Pharm. Co., Ltd.

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2025
  • Employees:
    500 - 999
Company types
Pharmaceutical company
View company profile

More Products from Hana Pharm. Co., Ltd. (5)

  • Dexmedetomidine HCI

    Product Dexmedetomidine HCI

    -Active Ingredients: Dexmedetomidine HCI -Dosage: 200mcg/2mL -Indication Sedation under intensive care management Conscious sedation for non-intubated patients during surgery and procedures -GMP: Korea GMP -Stability: Zone IV b
  • Isoflurane

    Product Isoflurane

    -Active Ingredients: Isoflurane -Dosage: 100mL -Indication General anesthesia -GMP: Korea GMP -Stability: Zone IV b
  • Propofol

    Product Propofol

    -Active Ingredients: Propofol -Dosage: 120mg/12mL, 200mg/20mL -Indication Induction and maintenance of general anesthesia Sedation of ventilated patients receiving intensive care Sedation of surgical and diagnostic procedures -GMP: Korea GMP -Stability: Zone IV b
  • Sevoflurane

    Product Sevoflurane

    -Active Ingredients: Sevoflurane -Dosage: 250mL -Indication General anesthesia -GMP: Korea GMP -Stability: Zone IV b
  • Byfavo Inj.

    Product Byfavo Inj.

    Byfavo Inj (remimazolam 20mg, 50mg) is an ultra–short–acting IV benzodiazepine sedative/anesthetic. It offers very rapid onset and offset of sedation, allowing quick patient recovery. In the body, remimazolam is rapidly metabolized by tissue esterases (not by CYP), which contributes to its brief duration a...